Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: I.M/I.V
Still deciding? Get samples of US$ 5/Piece
Request Sample
Gold Member Since 2020

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
In-stock Capacity
The supplier has In-stock capacity
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (9)
  • Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
  • Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
  • Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
  • Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
  • Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
  • Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
Find Similar Products

Basic Info.

State
Liquid
Shape
Injection
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
Available
Drug Ad Approval No.
Available
Factory Inspection
Available
Packing
Ampoules/Tray/Box
OEM Service
Available
MOQ
5000
Storage
Shading, Sealed Storage
Quality Standard
Bp, USP
Shelf Life
36 Months
Transport Package
Box/Carton
Specification
5ml: 1g
Trademark
Private logo service
Origin
China
Production Capacity
100000000000PCS/Month

Product Description

Levocarnitine Injection

 
PRODUCT NAME Vinpocetine Injection
Molecular formula C7H15NO3
Molecular weight
161.20
PACKING DETAILS: 5 ampoules/tray/box
STORAGE: Shading, sealed storage
SHELF LIFE: 36 months
Character Colorless clear liquid
CONSIGNMENT MANUFACTURING, BRAND OEM/ODM SERVICE IS AVAILABLE.
 

indication:
It is suitable for chronic renal failure patients with a series of concurrent symptoms caused by secondary carnitine deficiency, such as cardiomyopathy, skeletal myopathy, arrhythmia, hyperlipidemia, hypotension and muscle spasm during dialysis.

Usage and dosage:
After each hemodialysis, the recommended starting dose is 10-20mg / kg, dissolved in 5-10ml water for injection, intravenous injection once every 2-3 minutes. If the trough concentration of plasma levocarnidine is lower than normal (40-50umol / L), the treatment should be started immediately, and the dose should be adjusted at the third or fourth week of treatment (e.g. 5mg / kg during hemodialysis).

Adverse reactions:
The main causes are transient nausea and vomiting. The occurrence of special odor, nausea and gastritis is rare. It is difficult to estimate the incidence of these reactions due to the complex pathology.
Oral or intravenous L-carnitine can cause epileptic seizures. Patients with previous seizures can induce or aggravate epilepsy, regardless of whether they have a history of epilepsy.
In a double-blind, placebo-controlled trial of chronic hemodialysis patients, the main adverse reactions (regardless of causality, only those with an incidence of ≥ 5%) were as follows:
l) Systemic system: chest pain, cold symptoms, headache, injection site reaction, pain, etc;
2) Cardiovascular system: cardiovascular abnormalities, hypertension, hypotension, tachycardia, etc;
3) Digestive system: diarrhea, dyspepsia, nausea, vomiting, etc;
4) Endocrine system: thyroid abnormalities, etc;
5) Haemolymph system: anemia, etc;
6) Metabolic system: hypercalcemia, hyperkalemia, hypervolemia, etc;
7) Nervous system: dizziness, insomnia, depression, etc;
8) Respiratory system: cough, laryngitis, rhinitis, etc;
9) Skin: itching, rash;
10) Urinary system: abnormal renal function, etc.

taboo
It is not allowed to be allergic to this product.

matters needing attention
Before parenteral treatment, it is recommended to measure the plasma carnitine level, and to monitor weekly and monthly, including blood biochemistry, vital signs, plasma carnitine concentration (plasma free carnitine level is 35-60mol / L) and general condition.
Be sure to carefully observe whether there is any abnormality or discoloration before using drugs.
Pharmacokinetic and clinical studies show that L-carnitine can increase the plasma concentration of L-carnitine in hemodialysis patients with ESRD.

 
Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality


Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality
Western Medicine Levocarnitine Injection Bp USP 5ml with High Quality

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier